Growth Metrics

Biofrontera (BFRI) Shares Outstanding (Weighted Average) (2020 - 2025)

Biofrontera has reported Shares Outstanding (Weighted Average) over the past 6 years, most recently at $10.2 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 84.4% year-over-year to $10.2 million; the TTM value through Dec 2025 reached $10.2 million, up 84.4%, while the annual FY2025 figure was $10.2 million, 84.4% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $10.2 million at Biofrontera, up from $9.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $17.1 million in Q1 2022 and troughed at $941175.0 in Q2 2022.
  • A 5-year average of $5.8 million and a median of $5.6 million in 2024 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 799900.0% in 2021 and later tumbled 92.2% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $8.8 million in 2021, then tumbled by 88.0% to $1.1 million in 2022, then surged by 46.29% to $1.5 million in 2023, then soared by 256.74% to $5.5 million in 2024, then soared by 84.4% to $10.2 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for BFRI at $10.2 million in Q4 2025, $9.7 million in Q3 2025, and $9.1 million in Q2 2025.